Curexo Inc (060280) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.016x

Based on the latest financial reports, Curexo Inc (060280) has a cash flow conversion efficiency ratio of -0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.49 Billion ≈ $-1.01 Million USD) by net assets (₩94.30 Billion ≈ $63.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check Curexo Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Curexo Inc - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Curexo Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. See 060280 total equity for net asset value and shareholders' equity analysis.

Curexo Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Curexo Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
3I Group PLC LSE:III	0.001x
QORIA Ltd AU:QOR	-0.050x
Trailblazer Acquisition Corp. Class A Ordinary Shares NASDAQ:BLZR	0.000x
Trastor Real Estate Investment Company SA AT:TRASTOR	0.008x
Amorepacific Corp Pref KO:090435	-0.005x
Muang Thai Insurance Public Company Limited BK:MTI	0.031x
Kcc Glass Corp KO:344820	-0.004x
MFS Intermediate Income Trust NYSE:MIN	0.046x

Annual Cash Flow Conversion Efficiency for Curexo Inc (2012–2024)

The table below shows the annual cash flow conversion efficiency of Curexo Inc from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Curexo Inc (060280) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩93.38 Billion ≈ $63.28 Million	₩3.85 Billion ≈ $2.61 Million	0.041x	-18.50%
2023-12-31	₩100.43 Billion ≈ $68.06 Million	₩5.08 Billion ≈ $3.44 Million	0.051x	+131.58%
2022-12-31	₩81.68 Billion ≈ $55.35 Million	₩-13.08 Billion ≈ $-8.87 Million	-0.160x	+21.40%
2021-12-31	₩42.90 Billion ≈ $29.07 Million	₩-8.74 Billion ≈ $-5.92 Million	-0.204x	-496.60%
2020-12-31	₩44.79 Billion ≈ $30.36 Million	₩-1.53 Billion ≈ $-1.04 Million	-0.034x	+70.40%
2019-12-31	₩43.98 Billion ≈ $29.80 Million	₩-5.08 Billion ≈ $-3.44 Million	-0.115x	+46.85%
2018-12-31	₩70.03 Billion ≈ $47.46 Million	₩-15.20 Billion ≈ $-10.30 Million	-0.217x	-911.18%
2017-12-31	₩70.69 Billion ≈ $47.91 Million	₩-1.52 Billion ≈ $-1.03 Million	-0.021x	+97.33%
2016-12-31	₩73.08 Billion ≈ $49.53 Million	₩-58.79 Billion ≈ $-39.84 Million	-0.804x	-36.21%
2015-12-31	₩33.51 Billion ≈ $22.71 Million	₩-19.79 Billion ≈ $-13.41 Million	-0.591x	+58.96%
2014-12-31	₩13.94 Billion ≈ $9.45 Million	₩-20.06 Billion ≈ $-13.60 Million	-1.439x	-246.31%
2013-12-31	₩35.09 Billion ≈ $23.78 Million	₩-14.58 Billion ≈ $-9.88 Million	-0.416x	-4.98%
2012-12-31	₩49.48 Billion ≈ $33.53 Million	₩-19.59 Billion ≈ $-13.27 Million	-0.396x	--

About Curexo Inc

KQ:060280 Korea Food & Drug Retailing

Market Cap

$277.82 Million

₩409.96 Billion KRW

Market Cap Rank

#15376 Global

#550 in Korea

Share Price

₩12290.00

Change (1 day)

-5.46%

52-Week Range

₩7970.00 - ₩20350.00

All Time High

₩24400.00